Semaglutide authorised as Ozempic is not currently recognised by regulators as causing specific vulvovaginal adverse reactions such as vaginal dryness, vulvovaginal candidiasis, altered discharge, dyspareunia, vaginal atrophy, or vaginal mucosal injury
Once reconstituted, store the vial under refrigeration at 28C and use within the peptides documented stability window
Li ZY, Zhang N, Wen S, Zhang J, Sun XL, Fan XM et al (2017) Decreased glucagon-like peptide-1 correlates with abdominal pain in patients with constipation-predominant irritable bowel syndrome
The weight-loss story around GLP-1s is real
However, like MMA, false positive results may occur if one has kidney issues